www.sciencedaily.com
Researchers have developed an experimental antibody targeting a protein that fuels triple-negative breast cancer and suppresses the immune response. In early trials, this treatment slowed tumor growth, reduced lung metastases, and destroyed chemotherapy-resistant cells by effectively “turning the immune system back on.”
Read More
